A verdoheme-type compound was formed in the reaction of met-hemoCD2, an inclusion complex of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphinatoiron(III) (FeIIITPPS) with a per-O-methylated β-cyclodextrin dimer (Py2CD) having an OCH2PyCH2O (Py: pyridine-3,5-diyl) linker, with hydrogen peroxide (H2O2) in aqueous solution in the presence of 2-methoxyphenol (guaiacol). In the absence of guaiacol, met-hemoCD2 rapidly reacted with H2O2 to form a radical pair composed of an oxoferryl compound and a hydroxyl radical, which further reacted to yield unknown compounds. However, in the presence of guaiacol, one-electron reduction of the oxoferrylporphyrin afforded the original met-hemoCD2, which reacted with the hydroxyl radical remaining in the cyclodextrin cage to yield the verdoheme-type compound. A verdoheme-type compound was formed in the reaction of met-hemoCD2, an inclusion complex of 5,10,15,20-tetrakis(4-sulfonatophenyl)porphinatoiron(III) with a per-O-methylated β-cyclodextrin dimer, with hydrogen peroxide in aqueous solution in the presence of 2-methoxyphenol (guaiacol).
No takes yet. Share an insight, caveat, or question.
Kitagishi et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: